| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Alan J Russell is Chief Scientific Officer at EWTX. From September 2021 to August 2026, the filings on record show 0 open-market purchases and 23 sales. Alan J Russell's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.2M at current prices.
Historically, Alan J Russell's trades have earned a strong insider score of 74/100 across 38 rated trades. Over a 12-month horizon, 83.3% of those trades were profitable, with an average 12-month return of +20.8%.
The EWTX filings lean toward selling, a net 1,033,637 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 2021 | EWTX Edgewise Therapeutics, Inc. | Chief Scientific Officer | Sell | 5,778 | $18.24 | $105,409.04 | -3.2% | -10.3% | -42.1% | |
| Sep 29, 2021 | EWTX Edgewise Therapeutics, Inc. | Chief Scientific Officer | Sell | 26,454 | $17.10 | $452,483.04 | -12.9% | -11.8% | -43.5% | |
| Sep 27, 2021 | EWTX Edgewise Therapeutics, Inc. | Chief Scientific Officer | Sell | 58,546 | $18.30 | $1,071,421.94 | -22.2% | -19.7% | -47.1% |